4 European Projects Found
Searched on 125080 European Projects
FINISHED
Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy (MAGICBULLET)
Start date: Jan 1, 2015, End date: Dec 31, 2018,
Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are suitable as homing devices in tumor therapy. Conjugates of anticancer drugs with such a delivery vector targeting tumors would be a “magic bullet” according to the Nobel laureate Paul Ehrlich. Three antibody-drug conjugates (ADC) have already been approved for an ...
Read Project
9
Partners Participants
FINISHED
Understanding chronic pain and improving its treatment (EUROPAIN)
Start date: Oct 1, 2009, End date: Sep 30, 2015,
We will establish an international team of leading researchers and clinicians (EuroPain) to undertake multidisciplinary translational research which will: 1) increase the understanding of chronic pain mechanisms; 2)facilitate the development of novel analgesic drugs; and 3) improve the treatment of chronic pain patients.Nineteen researchers drawn from the London Pain Consortium, the Danish Pain Re ...
Read Project
29
Partners Participants
FINISHED
Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses (SILVER)
Start date: Oct 1, 2010, End date: Mar 31, 2015,
RNA virus infections kill millions of humans annually, largely due to the lack of suitable vaccines and drugs to control them. This problem is addressed in this FP7 call and in response a consortium of Europe’s and Asia’s leading molecular virologists, structural biologists, medicinal chemists and bioinformaticians has been brought together to generate a state-of-the-art drug discovery and design ...
Read Project
25
Partners Participants
FINISHED
European Training Network on (+)RNA Virus Replication and Antiviral Drug Development (EUVIRNA)
Start date: Mar 1, 2011, End date: Feb 28, 2015,
Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unmet need for potent antiviral drugs, in particular against viruses with a (+)RNA genome which include many important pathogens of humans and animals.Antiviral drug development requires a detailed understanding of virus replication and effective translation of th ...
Read Project
